TABLE 1.
UCSEMS | |
---|---|
n = 32 | |
Age, median (range), years | 79 (59–90) |
Sex, male, n (%) | 21 (65.6) |
Primary disease, n (%) | |
Bile duct cancer | 18 (56.3) |
Gallbladder cancer | 1 (3.1) |
Other cancers | 14 (43.8) |
Hepatocellular carcinoma | 2 (6.3) |
Gastric cancer | 1 (3.1) |
Malignant Lymphoma | 1 (3.1) |
Lymph node metastasis | 9 (28.1) |
Pancreatic duct dilation, n (%) | 0 |
Post‐cholecystectomy, n (%) | 2 (6.3) |
Tumor involvement at the orifice of the cystic duct, n (%) | 11 (34.4) |
Cholangitis before stent placement, n (%) | 17 (53.1) |
Chemotherapy after stent placement, n (%) | 10 (31.2) |
Complete response | 0 |
Partial response | 2 |
Stable disease | 2 |
Progressive disease | 6 |
Abbreviation: UCSEMS, uncovered self‐expandable metallic stent.